Chi Podcasts

Travis Schlappi from the California Institute of Technology recently sat down with CHI to discuss his poster “Featured Poster: 30 Minute Phenotypic Antibiotic Susceptibility Test Directly from Clinical Samples” which won the Diagnostics World Early Innovator Award at the Molecular Medicine Tri Conference this year. For more information, please visit http://www.TriConference.com/Student-Fellowship/

Georgios Kitsios of the University of Pittsburgh Medical Center spoke to CHI to discuss his latest research in rapid microbiome-based diagnostics of infectious disease and how he sees the microbiome filling a need in point-of-care diagnostics for infectious disease. He also discusses the epidemic of antibiotic resistance and how this has shaped his research in the critical care space, as well as the biggest challenges he and other scientists face in this field. Dr. Kitsios is speaking in the Advances in Microbiome Diagnostics symposium, taking place August 18, 2017 in DC as part of the Next Generation Dx Summit. For details, visit: http://www.NextGenerationDx.com/Microbiome-Diagnostics/

Cassandra Calloway of Children’s Hospital Oakland Research Institute and the Universities of California at Davis and San Francisco spoke to CHI to discuss how next generation sequencing, or massively parallel sequencing, is different from current methods used in DNA forensics. She discusses the benefits of this new technology and its potential for benefitting all forensics labs. Cassandra is speaking at NGS for DNA Forensics, taking place August 18, 2017 in DC as part of the Next Generation Dx Summit. For details, visit: http://www.NextGenerationDx.com

Charles River offers early discovery phase efficacy testing for novel therapies aimed at neurological and psychiatric conditions. Using a full range of different animal models, we use translational methods including in vitro assays, behavioral and cognitive testing and imaging to accelerate the development of novel CNS and neurological disease related therapies. Multi-modal study designs are essential for robust preclinical data that translate to success in the clinic. For more information, please visit http://www.WorldPreClinicalCongress.com/Translational-Strategies-CNS/

Robert Anders of Johns Hopkins Medicine speaks to CHI on May 16th, 2017. Dr. Anders will be speaking during the Biomarkers for Cancer Immunotherapy and Combinations meeting at the Next Generation Diagnostics Summit August 15-18th in Washington DC. Topics include the integration of genomic, proteomic and immunological markers for cancer immunotherapy, challenges in implementing multiplex approaches, and more. For more information, please visit http://www.NextGenerationDx.com/Biomarkers-Cancer-Immunotherapy/

Marc Williams of Geisinger Health System speaks to CHI on May 19th, 2017. Dr. Williams will be speaking during the Clinical NGS Assays: Applications and Interpretation meeting at the Next Generation Diagnostic Summit, August 15th to the 18th in Washington D.C. Topics include implementation of NGS in routine car, challenges to overcome and exciting applications of NGS. For more information, please visit http://www.NextGenerationDx.com/NGS-Diagnostics/

Jonathan Pan of Aevi Genomic Medicine speaks to CHI on May 15th, 2017. Dr. Pan will be speaking during the Companion Diagnostics: Strategy and Partnerships meeting at the Next Generation Diagnostic Summit, August 15th to the 18th in Washington D.C. Topics include precision medicine outside of oncology, unique genomic approaches, implementation in routine care and more. For more information, please visit http://www.NextGenerationDx.com/Companion-Diagnostics/

In this podcast from CHI on May 18th, Edana Holliday speaks about how Rx Clinic Pharmacy is working to integrate point-of-care testing and pharmacogenetic testing into their practice, and how use of these methods can bring doctors and pharmacists into new collaborations. To see her in person, check out the Pharmacy-Based Point-of-Care Testing conference, part of the Next Generation Diagnostics Summit, August 15-18th in Washington DC. For more information, please visit http://www.NextGenerationDx.com/Pharmacy-Diagnostics/

In this podcast from CHI, on May 11th, 2017 Liz Worthey, Faculty Investigator and Director at HudsonAlpha Institute for Biotechnology sat down to discuss her work in whole genome sequencing to diagnose and monitor rare diseases. She discusses her team’s work with standardizing NGS tests, utilizing sequencing as a diagnostic test, and challenges to making whole genome sequencing standard of care in clinical practice. To learn more, please visit http://www.NextGenerationDx.com/NGS-Based-Assays/

Omar Perez of Pfizer speaks to CHI on May 10, 2017. Dr. March will be speaking during the Companion Diagnostics: Strategy & Partnerships meeting at the Next Generation Diagnostics Summit, August 15-18th in Washington DC. Topics include using key commercialization challenges for precision medicine or companion diagnostics, starting the discussion between a diagnostic and a pharmaceutical company regarding co-commercialization and more. For more information, please visit http://www.NextGenerationDx.com/Companion-Diagnostics/

Keynote speaker Suzanne Belinson of Blue Cross Blue Shield Association speaks to CHI on May 9, 2017. Dr. Belinson will be speaking during the Coverage and Reimbursement of Advanced Diagnostics meeting at the Next Generation Diagnostics Summit, August 15-18th in Washington DC. Topics include using web-based platform where stakeholders can view evidence, if we need more standardized requirements for payers and regulators, and hopes for the conference. For more information please visit http://www.NextGenerationDx.com/Reimbursement-Diagnostics/

Cambridge Healthtech Institute interviews Dr. James Hickman, Professor of Nanoscience Technology, Chemistry, Biomolecular Science, and Electrical Engineering at the University of Central Florida regarding developing next-generation human body-on-a-chip systems to impact early drug discovery and basic research. For more information, please visit http://www.WorldPreclinicalCongress.com/Drug-Toxicity/ and http://www.WorldPreclinicalCongress.com/Disease-Modeling/

Alexis Sauer-Budge of Fraunhofer CMI and Boston University speaks to CHI on May 9, 2017. Dr. Sauer-Budge will be speaking during the Sample Preparation Track at the Biodefense World Summit, June 26-29, 2017, in Alexandria, VA. Traditionally, bacterial pathogens have been identified using culture-based methods that can take several days to obtain results. This can lead to physicians making treatment decisions based on an incomplete diagnosis. To decrease diagnosis time, we are developing novel devices and methods for isolating, concentrating, and detecting dilute viable pathogens and coupling these with novel downstream detection modalities.

Dr. Jeffrey Miller outlines what he considers to be some of the greatest obstacles to developing BiKEs and the new class of molecules called TriKEs, describes his method and what is unique about his approach, details unexpected discoveries, shares advice for introducing novel antibody therapeutics in the clinical setting and talks about what he considers some of the most exciting new developments emerging for bispecific antibody killer engagers. For more information, please visit http://www.PEGSummit.com/Bispecific-Antibodies-For-Oncology/

Yu Jin Park of Severance Hospital speaks to CHI on March 23, 2017. Mr. Park was a Poster Winner at the Molecular Medicine Tri-conference that ran this past February, 2017. Topics include using next generation sequencing in a gene panel for Autistic Spectrum Disorder(ASD). For more information, please visit http://www.NextGenerationDX.com/

Aidan Synnott of Charles River Laboratories speaks to CHI on May 3, 2017. Charles River Laboratories will be speaking during the Preclinical Models and Tools in Oncology - Part 1 and Tumor Models for Cancer Immunotherapy - Part 2, June 13-15,2017 in Boston, MA. Topics include overcoming challenges for cancer therapeutics, CAR-T cells, combination therapies and advice for drug companies looking to work with CROs For more information, please visit http://www.WorldPreclinicalCongress.com/Cancer-Models/ and http://www.WorldPreclinicalCongress.com/Tumor-Models-Immunotherapy/

CHI interviews Dr. Christoph Pittius, Vice President and Head of Transactions, Global Portfolio & Product Strategy, Business Development at AstraZeneca AB about current challenges and future trends of biopharma alliances. Discussion points and questions include: 1) How are biopharma alliances and deal-making evolving? What specific trends do you see developing? 2)What are some of the biggest challenges seen in deal-making today? What are critical steps necessary to overcome these challenges to maximize the value of strategic partnerships? 3) What is your outlook for the future of strategic partnerships and deal-making? 4)What types of partnerships do you think will increase over time? For more information, please visit http://www.Healthtech.com/AMS/

Kathleen Myers from AristaMD and Denise Gomez from North County Health Services recently sat down with CHI to discuss their upcoming presentations at Medical Informatics World. In this podcast they discuss the issues and challenges with current referral processes and how providers can leverage telehealth and eConsult platforms to improve communication and better patient care. For more information, please visit http://www.MedicalInformaticsWorld.com/Telehealth/

Mollie Shields-Uehling of SAFE-BioPharma Association and Tom Johnson of Exostar speak to Cambridge Healthtech Institute on March 23, 2017. Their organizations are represented by a co-presentation during the Data Security conference at Bio-IT World Conference & Expo, May 23-25 in Boston, Massachusetts. For more information, please visit http://www.Bio-ITWorldExpo.com/Data-Security/

Stuart S. Martin of University of Maryland School of Medicine speaks to Cambridge Healthtech Institute on March 17, 2017. He will be a presenter and short course instructor during The Liquid Biopsy Summit, June 21-23 in San Francisco, California. For more information, please visit http://www.LiquidBiopsySummit.com/